Playback speed
10 seconds
Lecture Summary - ASCO 2022 on the Phase 2/3 Study of an Individualized Neoantigen Vaccine + Immune Checkpoint Blockade as Maintenance for Newly Diagnosed mCRC
By
ASCO 2022 Conference Coverage
FEATURING
J. Randolph Hecht
By
ASCO 2022 Conference Coverage
FEATURING
J. Randolph Hecht
45 views
June 13, 2022
Login to view comments.
Click here to Login